InvestorsObserver
×
News Home

Should You Add Sensus Healthcare Inc (SRTS) Stock to Your Portfolio Thursday?

Thursday, January 13, 2022 01:20 PM | InvestorsObserver Analysts

Mentioned in this article

Should You Add Sensus Healthcare Inc (SRTS) Stock to Your Portfolio Thursday?

Sensus Healthcare Inc (SRTS) is near the top in its sector according to InvestorsObserver. SRTS gets an overall rating of 80. That means it scores higher than 80% of stocks. Sensus Healthcare Inc gets a 93 rank in the Healthcare sector. Healthcare is number 11 out of 11 sectors.

Overall Score - 80
SRTS has an Overall Score of 80. Find out what this means to you and get the rest of the rankings on SRTS!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 80 means the stock is more attractive than 80 percent of stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Sensus Healthcare Inc Stock Today?

Sensus Healthcare Inc (SRTS) stock is trading at $8.79 as of 1:18 PM on Thursday, Jan 13, a decline of -$0.01, or -0.11% from the previous closing price of $8.80. Volume today is below average. So far 156,762 shares have traded compared to average volume of 362,098 shares. The stock has traded between $8.04 and $8.94 so far today. Click Here to get the full Stock Report for Sensus Healthcare Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App